📣Managing locally advanced cervical cancer after the INTERLACE trial

INTERLACE: induction chemotherapy + CRT as new SOC in locally advanced cervical cancerПодробнее

Managing Locally Advanced Cervical CancerПодробнее

Highlights on pembro + CRT in high-risk locally advanced cervical cancer: The KEYNOTE-A18 studyПодробнее

How should locally advanced cervical cancer be treated?Подробнее

Shifting the focus to locally advanced cervical cancer: Improving patient outcomes through teamworkПодробнее

Induction chemotherapy added to chemoradiation improves PFS and OS in advanced cervical cancerПодробнее

Surgery of locally advanced cervical cancer (IB2-IIB) (Konstantin Morkhov)Подробнее

Adjuvant chemo following chemoradiation as treatment for locally advanced cervical cancer compar...Подробнее

2nd Oncology Beyond the Obvious (OBTO) In-Person Conference | Gynecological CancerПодробнее

Gynaecological Oncology : Management of Locally Advanced & Metastatic Cervical CancerПодробнее

Practical Perspectives on Rapid Change in Endometrial and Cervical Cancer ManagementПодробнее

Treatment Advances in Local-Regionally Advanced and Stage IVB/Recurrent Cervical Cancer: Can We A...Подробнее

Immunothearpy combo treating advanced cervical cancer | OSUCCC – JamesПодробнее

KEYNOTE 826: pembrolizumab + chemo in patients with advanced cervical cancerПодробнее

Ahead of Cancer | Cervical Cancer with Dr. Chris Morse | AHNПодробнее

Clinical Trials in Cervical Cancer: Can They Be All That We Want Them to Be? By Trey Leath, MDПодробнее

Metastatic and Recurrent Cervical Cancer TreatmentПодробнее

Linda Mileshkin, ESMO 2019 - Phase III OUTBACK trial in cervical cancerПодробнее